TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study

Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-05, Vol.65 (17), p.S39-S39
Hauptverfasser: Oyamada, Naofumi, Hamanaka, Ichiro, Fujie, Hiroaki, Ueda, Kinzo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S39
container_issue 17
container_start_page S39
container_title Journal of the American College of Cardiology
container_volume 65
creator Oyamada, Naofumi
Hamanaka, Ichiro
Fujie, Hiroaki
Ueda, Kinzo
description Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.
doi_str_mv 10.1016/j.jacc.2015.03.579
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1681532750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109715019233</els_id><sourcerecordid>3688510351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2239-39b723612aa2ceb0b302ad2495c3b1b3a2c83ccbb57c024f32c87a59404826763</originalsourceid><addsrcrecordid>eNp9kt-K1DAYxYsoOK6-gFcBb_Si3fyZNFMRoXSc7eCihR2vQ5qmOxm7yWySztK38Vn0xUx3BMELr0LC75x8nPMlyWsEMwRRfnnIDkLKDENEM0gyyoonyQJRukoJLdjTZAEZoSmCBXuevPD-ACHMV6hYJL921a5sQJlCRkGtb_fpZrAPoLImaDPa0YNa3dlOi14PwYmgrQFv601a1evNO7AenTa3oCqvgDAdaKrtZdNsQW8daJw6KfPI2_7Rzwkf0q3pRqk68EUd984eRdhPQBvQROdIe_Cgw_7nj7I7CTNjVYSMluCz7oyawFp7Jbx6D0rQ6MEGcBPGbnqZPOvF4NWrP-dF8m3zaVfV6fXXq21VXqcSY1KkpGgZJjnCQmCpWtgSiEWHlwWVpEUtia8rImXbUiYhXvYk3pmgxRIuVzhnOblI3px9j87ej8oHfrCjM_FLjmKalGBGYaTwmZLOeu9Uz49O3wk3cQT5XBY_8LksPpfFIeGxrCj6cBapOP9JK8e9jIHECLRTMvDO6v_LP_4jl4OOuYnhu5qU_zsm95hDfjNvw7wMiEJUYELIb6EAsZw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681532750</pqid></control><display><type>article</type><title>TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Oyamada, Naofumi ; Hamanaka, Ichiro ; Fujie, Hiroaki ; Ueda, Kinzo</creator><creatorcontrib>Oyamada, Naofumi ; Hamanaka, Ichiro ; Fujie, Hiroaki ; Ueda, Kinzo</creatorcontrib><description>Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2015.03.579</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Hydration ; Internal Medicine ; Kidney diseases ; Medical treatment ; Mortality</subject><ispartof>Journal of the American College of Cardiology, 2015-05, Vol.65 (17), p.S39-S39</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited May 5, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109715019233$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Oyamada, Naofumi</creatorcontrib><creatorcontrib>Hamanaka, Ichiro</creatorcontrib><creatorcontrib>Fujie, Hiroaki</creatorcontrib><creatorcontrib>Ueda, Kinzo</creatorcontrib><title>TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study</title><title>Journal of the American College of Cardiology</title><description>Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Hydration</subject><subject>Internal Medicine</subject><subject>Kidney diseases</subject><subject>Medical treatment</subject><subject>Mortality</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kt-K1DAYxYsoOK6-gFcBb_Si3fyZNFMRoXSc7eCihR2vQ5qmOxm7yWySztK38Vn0xUx3BMELr0LC75x8nPMlyWsEMwRRfnnIDkLKDENEM0gyyoonyQJRukoJLdjTZAEZoSmCBXuevPD-ACHMV6hYJL921a5sQJlCRkGtb_fpZrAPoLImaDPa0YNa3dlOi14PwYmgrQFv601a1evNO7AenTa3oCqvgDAdaKrtZdNsQW8daJw6KfPI2_7Rzwkf0q3pRqk68EUd984eRdhPQBvQROdIe_Cgw_7nj7I7CTNjVYSMluCz7oyawFp7Jbx6D0rQ6MEGcBPGbnqZPOvF4NWrP-dF8m3zaVfV6fXXq21VXqcSY1KkpGgZJjnCQmCpWtgSiEWHlwWVpEUtia8rImXbUiYhXvYk3pmgxRIuVzhnOblI3px9j87ej8oHfrCjM_FLjmKalGBGYaTwmZLOeu9Uz49O3wk3cQT5XBY_8LksPpfFIeGxrCj6cBapOP9JK8e9jIHECLRTMvDO6v_LP_4jl4OOuYnhu5qU_zsm95hDfjNvw7wMiEJUYELIb6EAsZw</recordid><startdate>20150505</startdate><enddate>20150505</enddate><creator>Oyamada, Naofumi</creator><creator>Hamanaka, Ichiro</creator><creator>Fujie, Hiroaki</creator><creator>Ueda, Kinzo</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150505</creationdate><title>TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study</title><author>Oyamada, Naofumi ; Hamanaka, Ichiro ; Fujie, Hiroaki ; Ueda, Kinzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2239-39b723612aa2ceb0b302ad2495c3b1b3a2c83ccbb57c024f32c87a59404826763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Hydration</topic><topic>Internal Medicine</topic><topic>Kidney diseases</topic><topic>Medical treatment</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oyamada, Naofumi</creatorcontrib><creatorcontrib>Hamanaka, Ichiro</creatorcontrib><creatorcontrib>Fujie, Hiroaki</creatorcontrib><creatorcontrib>Ueda, Kinzo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oyamada, Naofumi</au><au>Hamanaka, Ichiro</au><au>Fujie, Hiroaki</au><au>Ueda, Kinzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2015-05-05</date><risdate>2015</risdate><volume>65</volume><issue>17</issue><spage>S39</spage><epage>S39</epage><pages>S39-S39</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Recently, it was reported that continuous hemofiltration (CHF) could prevent CIN and reduce in-hospital mortality in advanced CKD-patients via both filtrating contrast and administration of alkaline agents.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2015.03.579</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2015-05, Vol.65 (17), p.S39-S39
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1681532750
source Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Cardiology
Cardiovascular
Hydration
Internal Medicine
Kidney diseases
Medical treatment
Mortality
title TCTAP A-075 High-Flow Continuous Hemodiafiltration (HF-CHDF) During CAG and PCI/PPI for Prevention of Contrast-Induced Nephropathy in Patients with Advanced Chronic Kidney Disease: A Pilot Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A20%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCTAP%20A-075%20High-Flow%20Continuous%20Hemodiafiltration%20(HF-CHDF)%20During%20CAG%20and%20PCI/PPI%20for%20Prevention%20of%20Contrast-Induced%20Nephropathy%20in%20Patients%20with%C2%A0Advanced%20Chronic%20Kidney%20Disease:%20A%20Pilot%20Study&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Oyamada,%20Naofumi&rft.date=2015-05-05&rft.volume=65&rft.issue=17&rft.spage=S39&rft.epage=S39&rft.pages=S39-S39&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2015.03.579&rft_dat=%3Cproquest_cross%3E3688510351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1681532750&rft_id=info:pmid/&rft_els_id=S0735109715019233&rfr_iscdi=true